Logo

Trump Administration Cuts $766M Funding to Moderna for Bird Flu Vaccine Projects

The Trump administration has retracted $766 million in funding awarded to Moderna for developing vaccines targeting pandemic influenza viruses, including H5N1 bird flu. Despite positive vaccine trial results and proven safety of Moderna’s mRNA technology, health officials have raised concerns. Meanwhile, the new highly contagious COVID-19 variant NB.1.81 has been detected in several US states, adding to public health complexities.

Trump Administration Cuts $766M Funding to Moderna for Bird Flu Vaccine Projects

The Trump administration has withdrawn $766 million in funding allocated to Moderna Inc., a leading American biotech firm developing vaccines for potential pandemic influenza viruses, including the H5N1 bird flu.

The Department of Health and Human Services (HHS) informed Moderna on Monday of its decision to retract funds previously awarded through the Biomedical Advanced Research and Development Authority (BARDA) program. These funds, granted in January and July 2025, were intended to support the development and procurement of Moderna’s investigational vaccines targeting bird flu and other pandemic threats.

Specifically, Moderna received $590 million in January and an additional $176 million in July to assess vaccine efficacy against pandemic influenza viruses.

Despite the funding withdrawal, Moderna emphasized the positive interim results from their latest vaccine candidate, mRNA-1018, which leverages the same mRNA technology used during the COVID-19 pandemic rollout. The company highlighted the robust immune response and favorable safety profile observed, expressing optimism about the vaccine’s potential.

However, Health Secretary Robert F. Kennedy voiced concerns regarding the company's vaccines, notwithstanding extensive evidence demonstrating their safety and effectiveness in preventing COVID-19 and saving millions of lives.

In parallel, public health officials are monitoring a newly identified highly contagious COVID-19 variant, NB.1.81, which has appeared in multiple US states including New York, Ohio, California, Rhode Island, Hawaii, Washington, and Virginia. First detected in late March and early April among international travelers, this variant contributes to ongoing pandemic challenges.

Last year, the H5N1 bird flu virus transmitted from wild birds to cattle, infecting hundreds of animals across several states. Human infections numbered around 70, including one fatality. Experts warn that ongoing mutations in the virus increase the risk of it becoming more virulent, with the potential to trigger a severe pandemic.

U.S. Removes Mercury Preservative from Flu Shots Amid Vaccine Debate
U.S. Removes Mercury Preservative from Flu Shots Amid Vaccine Debate

The Department of Health and Human Services announced it will eliminate the mercury-based preservative thimerosal from all flu vaccines in the U.S., a move propelled by vaccine panel recommendations and led by HHS Secretary Robert F. Kennedy Jr. While intended to reduce unnecessary mercury exposure, experts warn it may lower vaccination rates and fuel unproven fears linking thimerosal to developmental disorders. This decision highlights ongoing tensions between public health policy and vaccine skepticism in America.

Etienne-Emile Baulieu, Inventor of Abortion Pill, Passes Away at 98
Etienne-Emile Baulieu, Inventor of Abortion Pill, Passes Away at 98

Etienne-Emile Baulieu, the French endocrinologist who developed the abortion pill RU-486, died at 98. His medical advancements transformed women's reproductive rights worldwide. Baulieu also contributed to hormone research, neurodegenerative disease studies, and received numerous honors for his scientific work and dedication to improving human health.

Sarepta Shares Plummet 40% Amid FDA Scrutiny Over Gene Therapy Safety
Sarepta Shares Plummet 40% Amid FDA Scrutiny Over Gene Therapy Safety

Shares of Sarepta Therapeutics took a significant hit after the FDA signaled it may halt shipments of Elevidys, a gene therapy for Duchenne Muscular Dystrophy tied to multiple patient deaths. The therapy’s safety concerns come amidst controversial approvals and uncertain benefits, putting Sarepta's financial future and patient hope in jeopardy. Experts highlight the broader challenges of regulating breakthrough gene therapies balancing innovation with patient safety.

UK Government Unveils Transformative 10-Year NHS Health Plan
UK Government Unveils Transformative 10-Year NHS Health Plan

The UK's 10-year NHS plan promises a radical shift from hospital-centric to community-based care, enhanced digital services, and a strong focus on prevention. It includes the creation of neighborhood health centers, expansion of the NHS app, and increased training for healthcare workers. While welcomed as ambitious, the plan faces challenges including industry disputes and funding gaps, setting the stage for significant healthcare reform.

Trump Administration Cancels $766 Million Moderna Contract for Bird Flu Vaccine
Trump Administration Cancels $766 Million Moderna Contract for Bird Flu Vaccine

The Trump administration has retracted $766 million in funding previously granted to Moderna for its development of an mRNA-based vaccine targeting H5N1 bird flu. The funds, allocated via BARDA, were withdrawn despite Moderna reporting positive interim trial outcomes. The H5N1 virus poses a potential pandemic risk due to ongoing mutations. Moderna had planned late-stage trials supported by the canceled funds.

Trump Administration Cancels $700M Moderna Bird Flu Vaccine Funding
Trump Administration Cancels $700M Moderna Bird Flu Vaccine Funding

The Trump administration has rescinded more than $700 million in funding previously awarded to Moderna to develop its bird flu vaccine, including procurement rights. Earlier funding from both the Biden administration and the Department of Health and Human Services supported late-stage trials of Moderna's H5N1 vaccine. Despite cancellation, Moderna's mid-stage trials show positive results, and the company seeks alternative development options.

World Elders Abuse Awareness Day Rally Highlights Senior Citizens’ Struggles
World Elders Abuse Awareness Day Rally Highlights Senior Citizens’ Struggles

On World Elders Abuse Awareness Day, Vizianagaram’s Senior Citizens Welfare Association organized a rally to highlight the growing challenges faced by elderly individuals, including verbal abuse, forced isolation, and insufficient healthcare support. Leaders urged the government to ensure dignity and comprehensive care for senior citizens.

Drone Attack on Sudan Hospital Kills Six Amid Ongoing Conflict
Drone Attack on Sudan Hospital Kills Six Amid Ongoing Conflict

A suspected drone attack conducted by paramilitary forces targeted Obeid International Hospital in North Kordofan, Sudan, resulting in six deaths and multiple injuries. The strike caused severe structural damage, forcing the hospital to cease operations. Occurring amid Sudan’s civil war between the military and Rapid Support Forces, the assault adds to a growing list of violent incidents destabilizing the region and exacerbating a dire humanitarian crisis.

US Cancels $766M Moderna Bird Flu Vaccine Deal Amid Rising Infections
US Cancels $766M Moderna Bird Flu Vaccine Deal Amid Rising Infections

The US government has terminated a $766 million contract with Moderna for developing a bird flu vaccine, citing insufficient scientific and safety standards under HHS review. This decision coincides with increasing avian influenza cases affecting poultry and humans, including the first mammal-to-human H5N1 transmission in Texas. Moderna faces financial hurdles as the bird flu threat grows.

WHO Finalizes Global Pandemic Treaty Amid US Absence
WHO Finalizes Global Pandemic Treaty Amid US Absence

In March 2025, the WHO adopted a historic global pandemic treaty focused on enhancing international readiness and equitable access to vaccines and treatments. The U.S. chose not to participate, citing sovereignty concerns. The treaty commits nations to improve disease surveillance, healthcare capacity, and share intellectual property to ensure faster responses during pandemics. This landmark agreement could save millions of lives by addressing disparities exposed during COVID-19 and promoting fair global cooperation.

Undocumented Immigrant Arrested for Threatening to Shoot Former President Trump
Undocumented Immigrant Arrested for Threatening to Shoot Former President Trump

The Department of Homeland Security apprehended Ramon Morales Reyes, an undocumented Mexican immigrant, after he allegedly threatened to shoot former President Donald Trump. Reyes, who has a criminal record and a history of illegal border crossings, expressed anger towards Trump's deportation policies in a threatening letter. The arrest highlights continuing security concerns for political figures amid a backdrop of recent threats and attacks.

16 States Sue Trump Administration Over $1.4B NSF Grant Cuts
16 States Sue Trump Administration Over $1.4B NSF Grant Cuts

Sixteen states, led by New York, have filed a federal lawsuit against the Trump administration over $1.4 billion in cancelled NSF research grants. The suit contests cuts to STEM diversity programs and new funding caps on indirect research costs, arguing these moves threaten U.S. scientific leadership, economic strength, and national security.